Genetic Factors Associated with Tuberculosis-Related Clinical Outcomes in HIV-Infected Black African Patients: a Systematic Review and Meta-Analysis

References

• Chakaya J , KhanM , NtoumiFet al. Global Tuberculosis Report 2020 – reflections on the global TB burden, treatment and prevention efforts. Int. J. Infect. Dis.10.1016/j.ijid.2021.02.107 (2021).
   Web of Science ®Google Scholar
• Frank TD , CarterA , JahagirdarDet al. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV6(12), e831–e859 (2019).
   PubMed Web of Science ®Google Scholar
• Tuberculosis . https://www.unaids.org/en/topic/tuberculosis
   Google Scholar
• Ford N , MatteelliA , ShubberZet al. TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis. J. Int. AIDS Soc.19(1), 20714 (2016).
   PubMedGoogle Scholar
• Van Tong H , VelavanTP , ThyeT , MeyerCG. Human genetic factors in tuberculosis: an update. Trop. Med. Int. Health22(9), 1063–1071 (2017).
   PubMed Web of Science ®Google Scholar
• Huang L , LiuC , LiaoG , YangX , TangX , ChenJ. Vitamin D receptor gene FOKI polymorphism contributes to increasing the risk of tuberculosis: an update meta-analysis. Medicine94(51), e2256 (2015).
   PubMed Web of Science ®Google Scholar
• Xu C , TangP , DingCet al. Vitamin D receptor gene FOKI polymorphism contributes to increasing the risk of HIV-negative tuberculosis: evidence from a meta-analysis. 10(10), e0140634 (2015).
   Google Scholar
• Zhao L , LiuK , KongX , TaoZ , WangY , LiuY. Association of polymorphisms in Toll-like receptors 4 and 9 with risk of pulmonary tuberculosis: a meta-analysis. Med. Sci. Monit.21, 1097–1106 (2015).
   PubMed Web of Science ®Google Scholar
• Yi YX , HanJB , ZhaoL , FangY , ZhangYF , ZhouGY. Tumor necrosis factor alpha gene polymorphism contributes to pulmonary tuberculosis susceptibility: evidence from a meta-analysis. Int. J. Clin. Exp. Med8(11), 20690–20700 (2015).
   PubMed Web of Science ®Google Scholar
• Asiimwe IG , KiizaD , WalimbwaS , Sekaggya-WiltshireC. Genetic factors associated with tuberculosis-related outcomes in HIV-infected Black-African patients: a systematic review and meta-analysis protocol. Prospero (2021). www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021237551
   Google Scholar
• Moher D , LiberatiA , TetzlaffJ , AltmanDG. Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med.6(7), e1000097 (2009).
   PubMed Web of Science ®Google Scholar
• R Core Team . R: a language and environment for statistical computing (2018). https://www.R-project.org
   Google Scholar
• Jorgensen AL , WilliamsonPR. Methodological quality of pharmacogenetic studies: issues of concern. Stat. Med.27(30), 6547–6569 (2008).
   PubMed Web of Science ®Google Scholar
• Minelli C , ThompsonJR , AbramsKR , ThakkinstianA , AttiaJ. The choice of a genetic model in the meta-analysis of molecular association studies. Int. J. Epidemiol.34(6), 1319–1328 (2005).
   PubMed Web of Science ®Google Scholar
• Asiimwe IG , ZhangEJ , OsanlouRet al. Genetic factors influencing warfarin dose in Black-African patients: a systematic review and meta-analysis. Clin. Pharmacol. Ther.107(6), 1420–1433 (2020).
   PubMed Web of Science ®Google Scholar
• Schwarzer G . Meta: an R package for meta-analysis. R. News7(3), 40–45 (2007).
   Google Scholar
• Asiimwe IG , PushpakomS , TurnerRM , Kolamunnage-DonaR , JorgensenAL , PirmohamedM. Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis. Br. J. Clin. Pharmacol. doi:10.1111/bcp.14927 (2021) ( Epub ahead of print).
   Google Scholar
• Morales DR , ConoverMM , YouSCet al. Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit Health3(2), e98–e114 (2021).
   PubMedGoogle Scholar
• Higgins J , GreenSE. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] (2011).
   Google Scholar
• Ioannidis JP , BoffettaP , LittleJet al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int. J. Epidemiol.37(1), 120–132 (2008).
   PubMed Web of Science ®Google Scholar
• Fitness J , FloydS , WarndorffDKet al. Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am. J. Tropical Med. Hygiene71(3), 341–349 (2004).
   PubMed Web of Science ®Google Scholar
• Søborg C , AndersenAB , RangeNet al. Influence of candidate susceptibility genes on tuberculosis in a high endemic region. Mol. Immunol.44(9), 2213–2220 (2007).
   PubMed Web of Science ®Google Scholar
• Range N , AndersenAB , MagnussenP , MugomelaA , FriisH. The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomized controlled trial in Mwanza, Tanzania. Trop. Med. Int. Health10(9), 826–832 (2005).
   PubMed Web of Science ®Google Scholar
• Yimer G , UedaN , HabtewoldAet al. Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients. PLoS ONE6(12), e27810 (2011).
   PubMed Web of Science ®Google Scholar
• Benichou C . Criteria of drug-induced liver disorders. Report of an international consensus meeting. J. Hepatol.11(2), 272–276 (1990).
   PubMed Web of Science ®Google Scholar
• Hardwick RJ , AmogneW , MugusiSet al. β-defensin genomic copy number is associated with HIV load and immune reconstitution in sub-saharan Africans. J. Infect. Dis.206(7), 1012–1019 (2012).
   PubMed Web of Science ®Google Scholar
• Mugusi SF , NgaimisiE , JanabiMYet al. Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania. Antivir Ther17(2), 265–274 (2012).
   PubMed Web of Science ®Google Scholar
• Machado LR , BowdreyJ , NgaimisiEet al. Copy number variation of Fc gamma receptor genes in HIV-infected and HIV-tuberculosis co-infected individuals in sub-Saharan Africa. PloS ONE8(11), e78165 (2013).
   PubMed Web of Science ®Google Scholar
• Dhoro M , NgaraB , KadzirangeG , NhachiC , MasimirembwaC. Genetic variants of drug metabolizing enzymes and drug transporter (ABCB1) as possible biomarkers for adverse drug reactions in an HIV/AIDS cohort in Zimbabwe. Curr. HIV Res.11(6), 481–490 (2013).
   PubMed Web of Science ®Google Scholar
• Nemaura T , DhoroM , NhachiC , KadzirangeG , ChonziP , MasimirembwaC. Evaluation of the prevalence, progression and severity of common adverse reactions (lipodystrophy, cns, peripheral neuropathy, and hypersensitivity reactions) associated with anti-retroviral therapy (ART) and anti-tuberculosis treatment in outpatients in Zimbabwe. J. AIDS. Clin. Res.4(4), 1–7 (2013).
   Google Scholar
• Samie A , DzhivhuhoGA , NangammbiTC. Distribution of CXCR2 +1208 T/C gene polymorphisms in relation to opportunistic infections among HIV-infected patients in Limpopo Province, South Africa. Genet. Mol. Res.13(3), 7470–7479 (2014).
   PubMed Web of Science ®Google Scholar
• Samie A , MoloroGT , NangammbiTC. Interleukin-7 receptor gene polymorphism at +1237 locus and its effect on susceptibility to opportunistic infections among HIV and AIDS patients in Limpopo Province, South Africa. Genet. Mol. Res.13, 8757–8766 (2014).
   PubMed Web of Science ®Google Scholar
• Dzhivhuho GA , NangammbiTC , SamieA. Association of interleukin-8 gene polymorphisms in HIV patients with opportunistic infections in Limpopo Province, South Africa. Genet. Mol. Res.15(1), 15017466 (2016).
   PubMed Web of Science ®Google Scholar
• Sobota RS , SteinCM , KodamanNet al. A locus at 5q33.3 confers resistance to tuberculosis in highly susceptible individuals. Am. J. Hum. Genet.98(3), 514 (2016).
   PubMed Web of Science ®Google Scholar
• Sobota RS , SteinCM , KodamanNet al. A chromosome 5q31.1 locus associates with tuberculin skin test reactivity in HIV-positive individuals from tuberculosis hyper-endemic regions in east Africa. PLoS Genet.13(6), e1006710 (2017).
   PubMed Web of Science ®Google Scholar
• Petros Z , LeeMTM , TakahashiAet al. Genome-wide association and replication study of hepatotoxicity induced by antiretrovirals alone or with concomitant anti-tuberculosis drugs. OMICS21(4), 207–216 (2017).
   PubMed Web of Science ®Google Scholar
• Aithal GP , WatkinsPB , AndradeRJet al. Case definition and phenotype standardization in drug-induced liver injury. Clin. Pharmacol. Ther.89(6), 806–815 (2011).
   PubMed Web of Science ®Google Scholar
• Ravimohan S , NfanyanaK , TamuhlaN , TiemessenCT , WeissmanD , BissonGP. Common variation in NLRP3 is associated with early death and elevated inflammasome biomarkers among advanced HIV/TB co-infected patients in Botswana. Open Forum Infectious Dis.5(5), ofy075 (2018).
   PubMed Web of Science ®Google Scholar
• Ravimohan S , TamuhlaN , SteenhoffAPet al. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis. J. Infect. Dis.20811(1784), 1793 (2013).
   Google Scholar
• Calcagno A , CusatoJ , Sekaggya-WiltshireCet al. The influence of pharmacogenetic variants in HIV/tuberculosis coinfected patients in Uganda in the SOUTH study. Clin. Pharmacol. Ther.106(2), 450–457 (2019).
   PubMed Web of Science ®Google Scholar
• Sekaggya-Wiltshire C , Von BraunA , LamordeMet al. Delayed sputum culture conversion in tuberculosis-human immunodeficiency virus-coinfected patients with low isoniazid and rifampicin concentrations. Clin. Infect. Dis.67(5), 708–716 (2018).
   PubMed Web of Science ®Google Scholar
• Reid D , ShenoiS , LengLet al. Low expression macrophage migration inhibitory factor (MIF) alleles and tuberculosis in HIV infected South Africans. Cytokine: X1(1), 100004(2019).
   PubMedGoogle Scholar
• Mthiyane T , RustomjeeR , PymASet al. N-acetyltransferase 2 genotypes among Zulu-speaking South Africans and isoniazid and N-acetyl-isoniazid pharmacokinetics during antituberculosis treatment. Antimicrob. Agents Chemother.64(4), (2020).
   PubMed Web of Science ®Google Scholar
• Mcilleron H , RustomjeeR , VahediMet al. Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines. Antimicrob. Agents Chemother.56(6), 3232–3238 (2012).
   PubMed Web of Science ®Google Scholar
• Naiker S , ConnollyC , WiesnerLet al. Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy. BMC Pharmacol. Toxicol.15, 61 (2014).
   PubMed Web of Science ®Google Scholar
• Ravimohan S , MaenetjeP , AuldSCet al. A common NLRC4 gene variant associates with inflammation and pulmonary function in human immunodeficiency virus and tuberculosis. Clin. Infect. Dis.71(4), 924–932 (2020).
   PubMed Web of Science ®Google Scholar
• Seedat F , JamesI , LoubserSet al. Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household tuberculosis exposure and immune suppression. Tuberculosis126, 102023 (2021).
   PubMed Web of Science ®Google Scholar
• PharmGKB . Tuberculosis. (2021).
   Google Scholar
• Whirl-Carrillo M , McdonaghEM , HebertJMet al. Pharmacogenomics knowledge for personalized medicine. Clin. Pharmacol. Ther.92(4), 414–417 (2012).
   PubMed Web of Science ®Google Scholar
• Chen BF , WangR , ChenYJ , ZhuY , DingL , WenYF. Association between HLA-DRB1 alleles and tuberculosis: a meta-analysis. Genet. Mol. Res.14(4), 15859–15868 (2015).
   PubMedGoogle Scholar
• Li C , ZhouY , XiangX , ZhouY , HeM. The relationship of HLA-DQ alleles with tuberculosis risk: a meta-analysis. Lung193(4), 521–530 (2015).
   PubMed Web of Science ®Google Scholar
• De Albuquerque AC , RochaLQ , DeMorais Batista AH , TeixeiraAB , DosSantos DB , NogueiraNA. Association of polymorphism +874 A/T of interferon-gamma and susceptibility to the development of tuberculosis: meta-analysis. Eur. J. Clin. Microbiol. Infect. Dis.31(11), 2887–2895 (2012).
   PubMed Web of Science ®Google Scholar
• Thompson SG , HigginsJP. How should meta-regression analyses be undertaken and interpreted?Stat. Med.21(11), 1559–1573 (2002).
   PubMed Web of Science ®Google Scholar
• Matimba A , DhoroM , DandaraC. Is there a role of pharmacogenomics in Africa. Global Health Epidemiol. Genom.1 (2016).
   Google Scholar
• Campbell MC , TishkoffSA. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Ann. Rev. Genom. Hum. Genet.9(1), 403–433 (2008).
   PubMedGoogle Scholar
• Mboowa G , MwesigwaS , KatagiryaEet al. The Collaborative African Genomics Network (CAfGEN): applying Genomic technologies to probe host factors important to the progression of HIV and HIV-tuberculosis infection in sub-Saharan Africa. AAS Open Res.1, 3 (2018).
   PubMedGoogle Scholar